CDK12-HNF4A轴调控AKI肾小管损伤及机制研究，国家自然科学基金专项项目，2023.01- 2025.12，在研，主持，排1

巨噬细胞源性外泌体miR-155调控肾小管上皮细胞衰老的机制研究，国家自然科学基金面上项目，2021.01- 2024.12，在研，主持，排1

东南大学“至善青年项目”，东南大学，2022年，在研，主持，排1

托伐普坦在肾病患者容量管理中的精准应用，中国心血管健康联盟诺创高血压科研创新基金，2022-01-2024-01，在研，主持，排1

RVG修饰外泌体运载miR-26a对尿毒症心肌损害的治疗作用研究，江苏省自然科学基金面上项目，2018-07-01-2020-06-3010，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴对miR-26a表达调控的研究，国家自然科学基金青年项目，2017-08-06-2020-12-31，结题，主持，排1

成纤维细胞生长因子21与血液透析患者血管钙化的相关性研究和机制初探，中华医学会临床医学科研专项资金项目，2020-03-31-2022-03-31，结题，主持，排1

血液透析患者膈肌功能障碍的临床研究，江苏省“六大人才”高峰项目C类一项，2018-06-01-2020-12-31，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴.miR-26a表达调控的研究，东南大学高水平论文扶持项目，2018-01-01-2019-12-31，结题，主持，排1

CDK12-HNF4A轴调控AKI肾小管损伤及机制研究，国家自然科学基金专项项目，2023.01- 2025.12，在研，主持，排1

巨噬细胞源性外泌体miR-155调控肾小管上皮细胞衰老的机制研究，国家自然科学基金面上项目，2021.01- 2024.12，在研，主持，排1

东南大学“至善青年项目”，东南大学，2022年，在研，主持，排1

托伐普坦在肾病患者容量管理中的精准应用，中国心血管健康联盟诺创高血压科研创新基金，2022-01-2024-01，在研，主持，排1

RVG修饰外泌体运载miR-26a对尿毒症心肌损害的治疗作用研究，江苏省自然科学基金面上项目，2018-07-01-2020-06-3010，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴对miR-26a表达调控的研究，国家自然科学基金青年项目，2017-08-06-2020-12-31，结题，主持，排1

成纤维细胞生长因子21与血液透析患者血管钙化的相关性研究和机制初探，中华医学会临床医学科研专项资金项目，2020-03-31-2022-03-31，结题，主持，排1

血液透析患者膈肌功能障碍的临床研究，江苏省“六大人才”高峰项目C类一项，2018-06-01-2020-12-31，结题，主持，排1

醛固酮诱导TIF新机制：FOXO1/Rab7轴.miR-26a表达调控的研究，东南大学高水平论文扶持项目，2018-01-01-2019-12-31，结题，主持，排1

1.Wang B#, Wang Y#, Wen Y, Zhang YL, Ni WJ, Tang TT, et al. Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene. MOLECULAR THERAPY. 2022;30:3300-12. doi: 10.1016/j.ymthe.2022.05.012.

2.Wang B, Qian JY, Tang TT, Lin LL, Yu N, Guo HL, et al. VDR/Atg3 axis regulates slit diaphragm to tight junction transition via p62-mediated autophagy pathway in diabetic nephropathy. Diabetes. 2021. doi: 10.2337/db21-0205.

3.Wang B#, Wang ZM#, Ji JL, Gan W, Zhang A, Shi HJ, et al. Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy. JACC Basic Transl Sci. 2020;5:148-66. doi: 10.1016/j.jacbts.2019.10.011.

4.Tang TT#, Wang B#, Wu M, Li ZL, Feng Y, Cao JY, et al. Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv. 2020;6:z748. doi: 10.1126/sciadv.aaz0748.

5.Wang B, Zhang C, Zhang A, Cai H, Price SR, Wang XH. MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy. J Am Soc Nephrol. 2017;28:2631-40. doi: 10.1681/ASN.2016111213.

6.Tang TT#, Wang B#, Li ZL, Wen Y, Feng ST, Wu M, et al. Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI. J Am Soc Nephrol. 2021. doi: 10.1681/ASN.2020111561.

7.Yin Q, Zhao YJ, Ni WJ, Tang TT, Wang Y, Cao JY, et al, Liu BC*, Wang B*. MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury. Theranostics. 2022;12:4753-66. doi: 10.7150/thno.72456.

8.Zheng J, Yin Q, Wang SY, Wang YY, Xiao JJ, Tang TT, et al, Liu BC*, Wang B*. Ultrasound-assessed diaphragm dysfunction predicts clinical outcomes in hemodialysis patients. Sci Rep. 2022;12:16550. doi: 10.1038/s41598-022-20450-x.

9.Wang B, Wang GH, Ding XX, Tang HX, Zheng J, Liu BC, et al. Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in  hemodialysis patients. J Clin Hypertens (Greenwich). 2022;24:300-8. doi: 10.1111/jch.14422.

10.Gao YM, Feng ST, Wen Y, Tang TT, Wang B*, Liu BC*. Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolic reprogramming. EBioMedicine. 2022;83:104215. doi: 10.1016/j.ebiom.2022.104215.

11.Wang B, Li ZL, Zhang YL, Wen Y, Gao YM, Liu BC. Hypoxia and chronic kidney disease. EBioMedicine. 2022;77:103942. doi: 10.1016/j.ebiom.2022.103942.

12.Ni HF, Yang Y, Li CQ, Zhou TZ, Liu BC, Wang B*. Myeloid bodies caused by COQ2 mutation: a case of concurrent COQ2 nephropathy and IgA nephropathy. Clin Kidney J. 2021;14:1697-700. doi: 10.1093/ckj/sfab043.

13.Zhu L, Li M, Zha Q, Yang M, Yu J, Pan M, et al, Liu BC*, Wang B*. Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study. BMC Nephrology. 2021;22:183. doi: 10.1186/s12882-021-02393-z.

14.Wang FM, Yang Y, Zhang XL, Wang YL, Tu Y, Liu BC, Wang B*. Combination of a Novel Genetic Variant in CFB Gene and a Pathogenic Variant in COL4A5 Gene in a Sibling Renal Disease: A Case Report. Frontiers in Genetics. 2021;12:690952. doi: 10.3389/fgene.2021.690952.

15. Li ZL, Wang B*, Wen Y, Wu QL, Lv LL, Liu BC*. Disturbance of Hypoxia Response and Its Implications in Kidney Diseases. Antioxid Redox Signal. 2022. doi: 10.1089/ars.2021.0271.

16.12.Li ZL, Ji JL, Wen Y, Cao JY, Kharbuja N, Ni WJ, et al, Liu BC*, Wang B*. HIF-1alpha is transcriptionally regulated by NF-kappaB in acute kidney injury. Am J Physiol Renal Physiol. 2021;321:F225-35. doi: 10.1152/ajprenal.00119.2021.

17.Li ZL, Wang B*, Lv LL, Tang TT, Wen Y, Cao JY, et al, Liu BC*. FIH-1-modulated HIF-1alpha C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling. ACTA PHARMACOLOGICA SINICA. 2021;42:2106-19. doi: 10.1038/s41401-021-00617-4.

18. Wang H#, Wang B#, Zhang A, Hassounah F, Seow Y, Wood M, et al. Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice. Mol Ther. 2019;27:571-83. doi: 10.1016/j.ymthe.2019.01.008.

19. Wang B#, Zhang A#, Wang H, Klein JD, Tan L, Wang ZM, et al. miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease. Theranostics. 2019;9:1864-77. doi: 10.7150/thno.29579.

20. Cao JY#, Wang B#, Tang TT#, Wen Y, Li ZL, Feng ST, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11:5248-66. doi: 10.7150/thno.54550.

21. Wang B#, Wang J#, He W, Zhao Y, Zhang A, Liu Y, et al. Exogenous miR-29a Attenuates Muscle Atrophy and Kidney Fibrosis in Unilateral Ureteral Obstruction Mice. Hum Gene Ther. 2020;31:367-75. doi: 10.1089/hum.2019.287. 

22. Wang B, Yin Q, Wang YY, Tu Y, Han Y, Gao M, et al. Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional study. Sci Rep. 2019;9:19382. doi: 10.1038/s41598-019-56035-4.

23. Qian FY, Li ZL, Guo YD, Gao HC, Gu LH, Le K, et al, Wang B*，Zhang Z J*. Hypoxia-inducible factor-prolyl hydroxylase inhibitor ameliorates myopathy in a mouse model of chronic kidney disease. Am J Physiol Renal Physiol. 2019;317:F1265-73. doi: 10.1152/ajprenal.00260.2019.

24. Wang B, Guo H, Ling L, Ji J, Niu J, Gu Y. The Chronic Adverse Effect of Chloroquine on Kidney in Rats through an Autophagy  Dependent and Independent Pathways. Nephron. 2020;144:96-108. doi: 10.1159/000503882.

25. Tu Y, Sheng MJ, Wang YL, Wang ZJ, Zhang XL, Liu BC, Wang B*. A Woman With "Polycystic Kidney Disease". Kidney Int Rep. 2020;5:1367-70. doi: 10.1016/j.ekir.2020.05.026.

26. Wang B, Yin Q, Han YC, Wu M, Li ZL, Tu Y, et al. Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients. Ren Fail. 2020;42:912-25. doi: 10.1080/0886022X.2020.1811121.

27. Wang B, Li M, Tang F, Wang Y, Han Y, Lu W, et al. Event- and time-based prospective memory in hemodialysis patients. Ren Fail. 2020;42:1135-41. doi: 10.1080/0886022X.2020.1835673.

28. Jiang L, Yin Q, Yang M, Li M, Pan M, Han Y, et al, Wang B*. Fibroblast Growth Factor 21 Predicts and Promotes Vascular Calcification in Haemodialysis Patients. Kidney Dis (Basel). 2021;7:227-40. doi: 10.1159/000512750.